Cytlimic
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Cytlimic Information
Geographic Data
Address:
City: Higashi-shinagawa
State: Tokyo
Zip:
Country: Japan
Financial Info
Stage:
series b
Raised Last:
$12M
Raised Total:$21M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. CYTLIMIC’s products aim to activate immune systems to attack cancer cells while enabling patients to maintain a high quality-of-life during treatment.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2019 | Series B | 3 | $12.3M |
Fast Track Initiative, Inc. NEC Capital Solutions SMBC Venture Capital Fast Track Initiative, Inc. NEC Capital Solutions SMBC Venture Capital |
12/2016 | Seed Round | 1 | - |
Fast Track Initiative, Inc. Fast Track Initiative, Inc. |
12/2016 | Series A | 3 | $8.5M |
Fast Track Initiative, Inc. NEC Capital Solutions SMBC Venture Capital Fast Track Initiative, Inc. NEC Capital Solutions SMBC Venture Capital |
12/2016 | Seed Round | 1 | - |
Fast Track Initiative, Inc. Fast Track Initiative, Inc. |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
